Oxford BioMedica PLC (OXB)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
610.00p
Buy
612.00p
10.00p (+1.67%)
Prices updated at 11 Jun 2026, 17:09 BST
| Prices minimum 15 mins delay
Prices in GBX
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
22 May 202619 May 202613 May 202607 May 202630 Apr 202613 Apr 202608 Apr 202601 Apr 202630 Mar 202626 Mar 2026
Key dates
| Forecast date | |
|---|---|
| Annual general meeting | May 2027 |
| Annual report | Mar 2027 |
| Final results | Mar 2027 |
| Half yearly results | Sep 2026 |
| Previous date | |
|---|---|
| Annual general meeting | May 2026 |
| Annual report | Mar 2026 |
| Final results | Mar 2026 |
| Half yearly results | Sep 2025 |
Company reports
31 Dec 2025
Annual Report 30 Jun 2012
Quarterly Report 